Zynerba Pharmaceuticals, INC.

health/governmental assistance before FDA

Based in PA

🤖

AI Overview

With $400K in lobbying spend across 15 quarterly filings, Zynerba Pharmaceuticals, INC is an active lobbying client. Their lobbying covers 3 issue areas. Active from 2020 to 2023.

$400K

Total Spend

Years Active

Firms Hired

Lobbyists Deployed

Issues Lobbied

Spending Trend

View as table

Year	Lobbying Spend
2020	$45K
2021	$165K
2022	$80K
2023	$110K

Issues Lobbied

Government Issues Health Issues Pharmacy

Lobbying Firms

Watkins & Eager PLLC

Lobbyists

Gregg Harper

What They Lobby About

These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Government Issues, Health Issues, Pharmacy

•Assist in the development & approval process before the FDA of Zynerba's lead therapeutic for the potential treatment of behavioral symptoms associated with Fragile X Syndrome.

•Brief key House & Senate Members and/or appropriate staff on need and justification for this product. Secure letter of support for applications from key House & Senate Members.

•Support Zynerba and its partners, and any other of its contractors in its process before the FDA; Troubleshoot inevitable issues and eligibility hurdles to ensure the project is considered for approva